|
|
Previous Article | Table of Contents | Next Article 
Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl)
retinamide and effect of deregulated bcl-2
D Delia, A Aiello, F Formelli, E Fontanella, A Costa, T Miyashita, JC Reed and MA Pierotti
Istituto Nazionale Tumori, European Institute of Oncology, Milan, Italy.
The cancer chemopreventive retinoid N-(4-hydroxyphenyl)-all-trans
retinamide (HPR) was recently shown by us to have antiproliferative and
apoptotic effects on human leukemic cell lines, including those
unresponsive to all-trans retinoic acid (ATRA). We have now characterized
further the process of HPR-induced cell death. We report that inhibitors of
RNA transcription and of protein synthesis, activators of protein kinase C
(PKC), inhibitors of tyrosine kinases, Zn++, and the antioxidants
acetylcysteine, ascorbic acid, alpha- tocopherol, and deferoxamine
suppressed HPR-induced apoptosis. HL60 cells induced toward monocytic
differentiation by 1,25 dihydroxyvitamin- D3 [1,25(OH)2D3], but not those
induced toward the granulocytic differentiation by ATRA, showed reduced
responses to HPR. The transport of HPR by cells with different sensitivity
to the retinoid, however, was similar, even after treatment with the
phorbol ester 12-O- tetradecanoylphorbol-13-acetate (TPA), which induces
unresponsiveness to HPR. The expression of the apoptosis-related genes
bcl-2, p53, and c- myc was examined to determine their role in
HPR-triggered cell death. The levels of bcl-2 mRNA were markedly diminished
by 24 hours of HPR treatment in all cell lines except in the relatively
HPR-insensitive line K422. However, probably because of its long half-life,
bcl-2 protein levels were either unchanged or only slightly decreased.
Downregulation of p53 mRNA was also observed within 24 hours of HPR
exposure in NB4 but not K422 cells, but no changes in the amount of p53
protein were found. Suppression of c-myc transcription was observed in all
cells except K422. The protective role of bcl-2 on cell death by HPR was
investigated in HL60 as well as 697 pre-B leukemia and Jurkat T- acute
lymphocytic leukemia (T-ALL) cells constitutively expressing high levels of
bcl-2 proteins due to gene transfer manipulation. Compared with control
cells, the onset of apoptosis in these cells with deregulated bcl-2
production was delayed by at least 24 hours. These findings establish that
cell death by HPR requires RNA transcription and protein synthesis and is
regulated by the activation of PKC. Although changes in bcl-2, p53, and
c-myc expression are found in cells treated with HPR, the time-course of
these events suggests that HPR- triggered apoptosis is not directly
controlled by these genes. Finally, while ectopic overexpression of bcl-2
does not protect cells from death by HPR, it markedly delays its
onset.(ABSTRACT TRUNCATED AT 400 WORDS)
Volume 85,
Issue 2,
pp. 359-367,
01/15/1995
Copyright © 1995 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H.-J. Chiu, D. A. Fischman, and U. Hammerling
Vitamin A depletion causes oxidative stress, mitochondrial dysfunction, and PARP-1-dependent energy deprivation
FASEB J,
November 1, 2008;
22(11):
3878 - 3887.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Maurer, O. Kalous, D. W. Yesair, X. Wu, J. Janeba, V. Maldonado, V. Khankaldyyan, T. Frgala, B.-C. Sun, R. T. McKee, et al.
Improved Oral Delivery of N-(4-Hydroxyphenyl)Retinamide with a Novel LYM-X-SORB Organized Lipid Complex
Clin. Cancer Res.,
May 15, 2007;
13(10):
3079 - 3086.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. P. Schroeder, H. Kadara, D. Lotan, J. K. Woo, H.-Y. Lee, W. K. Hong, and R. Lotan
Involvement of Mitochondrial and Akt Signaling Pathways in Augmented Apoptosis Induced by a Combination of Low Doses of Celecoxib and N-(4-Hydroxyphenyl) Retinamide in Premalignant Human Bronchial Epithelial Cells
Cancer Res.,
October 1, 2006;
66(19):
9762 - 9770.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Villani, V. Appierto, E. Cavadini, A. Bettiga, A. Prinetti, M. Clagett-Dame, R. W. Curley, and F. Formelli
4-Oxo-Fenretinide, a Recently Identified Fenretinide Metabolite, Induces Marked G2-M Cell Cycle Arrest and Apoptosis in Fenretinide-Sensitive and Fenretinide-Resistant Cell Lines.
Cancer Res.,
March 15, 2006;
66(6):
3238 - 3247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Shishodia, A. M. Gutierrez, R. Lotan, and B. B. Aggarwal
N-(4-Hydroxyphenyl)Retinamide Inhibits Invasion, Suppresses Osteoclastogenesis, and Potentiates Apoptosis through Down-regulation of I{kappa}B{alpha} Kinase and Nuclear Factor-{kappa}B-Regulated Gene Products
Cancer Res.,
October 15, 2005;
65(20):
9555 - 9565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nencioni, L. Wille, G. Dal Bello, D. Boy, G. Cirmena, S. Wesselborg, C. Belka, P. Brossart, F. Patrone, and A. Ballestrero
Cooperative Cytotoxicity of Proteasome Inhibitors and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Chemoresistant Bcl-2-Overexpressing Cells
Clin. Cancer Res.,
June 1, 2005;
11(11):
4259 - 4265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. W. Sherrill, M. P. Byrd, M. E. Van Eden, and R. E. Lloyd
BCL-2 Translation Is Mediated via Internal Ribosome Entry during Cell Stress
J. Biol. Chem.,
July 9, 2004;
279(28):
29066 - 29074.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Gopal, J. M. Pagel, N. Hedin, and O. W. Press
Fenretinide enhances rituximab-induced cytotoxicity against B-cell lymphoma xenografts through a caspase-dependent mechanism
Blood,
May 1, 2004;
103(9):
3516 - 3520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pirkmaier, K. Yuen, J. Hendley, M. J. O'Connell, and D. Germain
Cyclin D1 Overexpression Sensitizes Breast Cancer Cells to Fenretinide
Clin. Cancer Res.,
May 1, 2003;
9(5):
1877 - 1884.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Erdreich-Epstein, L. B. Tran, N. N. Bowman, H. Wang, M. C. Cabot, D. L. Durden, J. Vlckova, C. P. Reynolds, M. F. Stins, S. Groshen, et al.
Ceramide Signaling in Fenretinide-induced Endothelial Cell Apoptosis
J. Biol. Chem.,
December 13, 2002;
277(51):
49531 - 49537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-R. You, J. Wen, S.-T. Lee, and D.-G. Kim
Cytochrome c Oxidase Subunit III. A MOLECULAR MARKER FOR N-(4-HYDROXYPHENYL)RETINAMIDE-INDUCED OXIDATIVE STRESS IN HEPATOMA CELLS
J. Biol. Chem.,
February 1, 2002;
277(6):
3870 - 3877.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Shan, A. K. Gopal, and O. W. Press
Synergistic Effects of the Fenretinide (4-HPR) and Anti-CD20 Monoclonal Antibodies on Apoptosis Induction of Malignant Human B Cells
Clin. Cancer Res.,
August 1, 2001;
7(8):
2490 - 2495.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Ponzanelli, M. Gianni, R. Giavazzi, A. Garofalo, I. Nicoletti, U. Reichert, E. Erba, A. Rambaldi, M. Terao, and E. Garattini
Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid
Blood,
April 15, 2000;
95(8):
2672 - 2682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Reed
Fenretinide: the Death of a Tumor Cell
J Natl Cancer Inst,
July 7, 1999;
91(13):
1099 - 1100.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Maurer, L. S. Metelitsa, R. C. Seeger, M. C. Cabot, and C. P. Reynolds
Increase of Ceramide and Induction of Mixed Apoptosis/Necrosis by N-(4-Hydroxyphenyl)- retinamide in Neuroblastoma Cell Lines
J Natl Cancer Inst,
July 7, 1999;
91(13):
1138 - 1146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Monczak, M. Trudel, W. W. Lamph, and W. H. Miller Jr
Induction of Apoptosis Without Differentiation by Retinoic Acid in PLB-985 Cells Requires the Activation of Both RAR and RXR
Blood,
November 1, 1997;
90(9):
3345 - 3355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. Fanjul, D. Delia, M. A. Pierotti, D. Rideout, J. Qiu, and M. Pfahl
4-Hydroxyphenyl Retinamide Is a Highly Selective Activator of Retinoid Receptors
J. Biol. Chem.,
September 13, 1996;
271(37):
22441 - 22446.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Nishikawa, B. I. Carr, M. Wang, S. Kar, F. Finn, P. Dowd, Z. B. Zheng, J. Kerns, and S. Naganathan
Growth Inhibition of Hepatoma Cells Induced by Vitamin K and Its Analogs
J. Biol. Chem.,
November 24, 1995;
270(47):
28304 - 28310.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|